For example, the multidrug resistance protein ABCG2 has been implicated in the development of OXA resistance in CRC [41], and the inhibition of miR-483-3p has been shown to confer OXA resistance in CRC cell lines [42]. This evidence concerns the gene ABCG2 and colorectal carcinoma.